{"gene":"ARID1B","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2002,"finding":"ARID1B (hELD/OSA1) was cloned as a human homolog of Drosophila Eld/Osa and shown to be a component of endogenous SWI/SNF complexes. The EHD2 domain of ARID1B mediates direct binding to BRG1 (SMARCA4), the ATPase subunit of SWI/SNF. EHD1 and EHD2 domains can also interact with each other. An ARID domain was identified as a putative DNA-binding domain.","method":"Domain mapping, co-immunoprecipitation from mouse brain extracts, antibody against EHD2","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding interaction mapped by domain co-IP, single lab, two orthogonal methods (co-IP + domain deletion)","pmids":["11988099"],"is_preprint":false},{"year":2008,"finding":"BAF250B (ARID1B)-containing SWI/SNF complex is required for mouse embryonic stem cell self-renewal and normal cell cycle progression. Biallelic inactivation of BAF250B in ES cells reduced proliferation, impaired self-renewal, and altered expression of pluripotency and differentiation genes.","method":"Biallelic gene inactivation in mouse ES cells, proliferation assays, gene expression analysis, cell cycle analysis","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout with defined cellular phenotype, multiple orthogonal readouts (cell cycle, pluripotency gene expression, self-renewal assay)","pmids":["18323406"],"is_preprint":false},{"year":2011,"finding":"ARID1A and ARID1B are mutually exclusive subunits of the BAF complex with different cell-cycle expression kinetics: ARID1A accumulates in G0 and is eliminated during mitosis, whereas ARID1B is expressed at comparable levels throughout all cell cycle phases including mitosis, suggesting differential incorporation into SWI/SNF during proliferation versus arrest.","method":"Immunofluorescence, western blotting across synchronized cell cycle phases, expression analysis in mouse embryos","journal":"Cell and tissue research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization and protein-level cell cycle analysis, single lab, two methods","pmids":["21647563"],"is_preprint":false},{"year":2014,"finding":"ARID1B is a specific vulnerability in ARID1A-mutant cancers. ARID1B is the paralog that is mutually exclusive with ARID1A in SWI/SNF (cBAF) complexes. Loss of ARID1B in an ARID1A-deficient background destabilizes the SWI/SNF complex and impairs proliferation in cancer cells and primary cells.","method":"Broad siRNA/shRNA screening, genetic loss-of-function in cancer cell lines, protein complex stability assays (co-IP/western blot), proliferation assays","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic screening plus mechanistic validation (complex stability, proliferation), replicated across multiple cell lines","pmids":["24562383"],"is_preprint":false},{"year":2014,"finding":"Both ARID1A and ARID1B are required for efficient non-homologous end joining (NHEJ) of DNA double-strand breaks. Suppression of either protein reduces KU70/KU80 accumulation at DSBs and sensitizes cells to ionizing radiation, cisplatin, and UV. Both ARID1 proteins facilitate recruitment of the SWI/SNF ATPase subunit to DSBs. ARID1A and ARID1B show interdependent protein stability within the complex.","method":"siRNA knockdown, live-cell imaging of DSB repair, KU70/KU80 focus assays, clonogenic survival, co-immunoprecipitation","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (live imaging, focus assays, survival assays, co-IP), single lab with rigorous controls","pmids":["24788099"],"is_preprint":false},{"year":2014,"finding":"ARID1B haploinsufficiency in patient-derived fibroblasts causes delayed cell cycle re-entry after serum starvation, with reduced cell numbers in S phase, providing direct evidence that altered cell cycle dynamics underlie ARID1B-associated disorders.","method":"Cell cycle analysis (BrdU/flow cytometry) in patient-derived and ARID1B knockdown fibroblasts after serum starvation","journal":"Orphanet journal of rare diseases","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient-derived cells plus knockdown model, single lab, single assay type","pmids":["24674232"],"is_preprint":false},{"year":2015,"finding":"ARID1B is a repressor of Wnt/β-catenin signaling. Knockdown of ARID1B activates Wnt/β-catenin target genes and transcriptional reporters in a β-catenin-dependent manner. Endogenous and exogenous ARID1B associate with β-catenin. ARID1B represses Wnt/β-catenin-mediated transcription through the BAF core subunit BRG1. Mutations in ARID1B that delete its BRG1-binding domain compromise association with β-catenin and fail to suppress Wnt signaling. ARID1B knockdown in mouse neuroblastoma cells promotes neurite outgrowth through β-catenin.","method":"Transcriptome analysis, Wnt reporter assays, siRNA knockdown, co-immunoprecipitation (endogenous and exogenous), domain-deletion mutagenesis, neurite outgrowth assay","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (co-IP, reporter assay, mutagenesis, transcriptome, cellular phenotype), single lab","pmids":["26340334"],"is_preprint":false},{"year":2015,"finding":"ARID1B knockdown in breast cancer cells (MDA-MB-231) causes delay in G1-to-S phase cell cycle transition and decreased cell proliferation, establishing a direct role for ARID1B in cell cycle progression.","method":"siRNA knockdown, flow cytometry cell cycle analysis, proliferation assay","journal":"Histopathology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single knockdown experiment with cell cycle readout, limited mechanistic depth","pmids":["25817822"],"is_preprint":false},{"year":2016,"finding":"P-STAT3 represses Arid1b expression through BRG1-dependent histone modification, leading to increased β-catenin activity in Schwann cell progenitors. Arid1b acts downstream of STAT3 as part of an Nf1-Stat3-Arid1b/β-catenin neurofibroma initiation pathway. Knockdown of Arid1b rescues neurofibroma formation in Stat3-deficient SCPs after in vivo transplantation.","method":"Insertional mutagenesis screen, mouse genetic models (conditional knockouts), ChIP for histone marks, in vivo transplantation, genetic epistasis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis via genetic models, mechanistic ChIP data, in vivo transplantation rescue, multiple orthogonal approaches","pmids":["26904939"],"is_preprint":false},{"year":2016,"finding":"ARID1B is required for dendritic arborization and spine morphology of developing pyramidal neurons. ARID1B knockdown suppresses dendritic arborization of cortical and hippocampal pyramidal neurons, causes aberrant dendritic spines and impaired synaptic transmission, and reduces expression of c-Fos and Arc; overexpression of c-Fos and Arc rescues the dendritic differentiation defects.","method":"In utero electroporation-mediated knockdown, confocal imaging of dendritic morphology, electrophysiology, gene expression analysis, rescue experiments with c-Fos/Arc overexpression","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — in utero knockdown with morphological and electrophysiological readouts plus genetic rescue, multiple orthogonal methods","pmids":["26937011"],"is_preprint":false},{"year":2017,"finding":"Arid1b haploinsufficiency in mice reduces cortical GABAergic interneuron numbers and proliferation of interneuron progenitors in the ganglionic eminence, leads to E/I synaptic imbalance in the cerebral cortex, and suppresses H3K9 acetylation globally and specifically at the Pvalb promoter, resulting in decreased parvalbumin transcription.","method":"Arid1b knockout mouse model (heterozygotes), cell counting, BrdU proliferation assay, ChIP for H3K9ac, qRT-PCR, synaptic electrophysiology","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (ChIP, electrophysiology, cell counting, BrdU), validated in mouse model with defined molecular mechanism","pmids":["29184203"],"is_preprint":false},{"year":2017,"finding":"Arid1b haploinsufficiency in mice causes IGF1 deficiency with inadequate GHRH/GH compensation, leading to growth retardation and muscle weakness. GH supplementation corrects growth retardation but not behavioral abnormalities. Arid1b haploinsufficiency alters expression of SWI/SNF-regulated genes implicated in neuropsychiatric disorders.","method":"Arid1b heterozygous mouse model, serum IGF1/GH measurements, GH supplementation rescue, gene expression analysis","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mouse model with hormonal measurements and rescue experiment, single lab","pmids":["28695822"],"is_preprint":false},{"year":2020,"finding":"Dual loss of ARID1A and ARID1B causes aggressive carcinogenesis through de-differentiation and hyperproliferation in liver and skin. Residual cBAF subcomplexes from loss of ARID1 scaffolding unexpectedly disrupt polybromo-containing pBAF function. Mutations in conserved scaffolding domains of ARID1 proteins cause complex disassembly. In double-mutant endometrial cancer cells, add-back of either ARID1A or ARID1B induced senescence.","method":"Double-knockout mouse models (liver, skin), endometrial cancer cell lines, biochemical fractionation of SWI/SNF subcomplexes, domain mutation analysis, senescence assays","journal":"Nature cancer","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo double-KO models, biochemical complex analysis, cell-based rescue, multiple orthogonal approaches","pmids":["34386776"],"is_preprint":false},{"year":2020,"finding":"Arid1b haploinsufficiency in parvalbumin (PV) interneurons causes social and emotional impairments, while deletion in somatostatin (SST) interneurons causes stereotypies and learning/memory dysfunction, demonstrating interneuron subtype-specific contributions to ARID1B-associated behavioral phenotypes.","method":"Cell-type-specific conditional Arid1b knockout mice (PV-Cre and SST-Cre), behavioral testing","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with cell-type specificity and behavioral readouts, single lab","pmids":["32398858"],"is_preprint":false},{"year":2020,"finding":"Arid1b deficiency in zebrafish embryos reduces body length and perturbs expression of chondrogenic and osteogenic genes (sox9a, col2a1a, runx2b, col10a1). Knockout of Arid1b in chondrogenic ATDC5 cells inhibits chondrocyte proliferation and differentiation. Wnt/β-catenin signaling is perturbed in Arid1b-depleted zebrafish and Arid1b-KO ATDC5 cells, linking ARID1B to bone growth via Wnt/β-catenin regulation.","method":"Zebrafish arid1b morpholino knockdown, Arid1b KO in ATDC5 cells, qRT-PCR for osteogenic genes, Wnt reporter assays, proliferation/differentiation assays","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two model systems (zebrafish, cell line), pathway (Wnt) validation, single lab","pmids":["31981384"],"is_preprint":false},{"year":2021,"finding":"ARID1B is present only during the neuroectoderm specification stage of cranial neural crest cell formation and is part of a lineage-specific ARID1B-BAF configuration. At the onset of differentiation, cells transition from ARID1A-BAF to ARID1B-BAF, which attenuates NANOG and SOX2 network enhancers and genes to drive exit from pluripotency. In ARID1B+/- patient iPSCs, this ARID1A-to-ARID1B-BAF switch fails, maintaining NANOG/SOX2 activity and impairing neural crest formation.","method":"Patient-derived iPSCs (ARID1B+/-), ATAC-seq, ChIP-seq, RNA-seq, CUT&RUN for BAF subunits during CNCC differentiation","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple genomic methods (ATAC-seq, ChIP-seq, RNA-seq) in patient iPSCs with mechanistic pathway identification, single lab but rigorous multi-omic approach","pmids":["34753942"],"is_preprint":false},{"year":2021,"finding":"ARID1B deletion in ventral (inhibitory) neural progenitors decreases proliferation, alters cell cycle regulation, increases cell death, and decreases nuclear β-catenin localization in Arid1b-deficient neurons. Conditional homozygous deletion of Arid1b in ventral neural progenitors produces pronounced ID- and ASD-like behaviors, whereas deletion in cortical progenitors produces only minor cognitive deficits.","method":"Conditional and global Arid1b KO mouse models, BrdU proliferation assays, TUNEL apoptosis, immunofluorescence for β-catenin localization, behavioral testing","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with cell-type specificity, subcellular localization by IF, behavioral phenotype, single lab","pmids":["33594090"],"is_preprint":false},{"year":2021,"finding":"TNPO1 mediates nuclear import of ARID1B. In ARID1A-deficient gynecologic cancer cells, TNPO1 knockdown phenocopies ARID1B knockdown. TNPO1 or ARID1B knockdown reduces H3K4me1 and H3K27ac marks, decreases AP-1 family transcription factor binding, and inactivates PI3K/AKT signaling by reducing PIK3CA and FGFR2 expression.","method":"Gene expression profiling, siRNA knockdown, Co-IP, chromatin accessibility assays (ATAC-seq), ChIP for histone marks, in vitro and in vivo tumor growth assays","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — nuclear import mechanism identified by knockdown and co-IP, chromatin changes validated, single lab","pmids":["34044070"],"is_preprint":false},{"year":2021,"finding":"ARID1B directly interacts with the lncRNA NEAT1 of paraspeckles, mediating paraspeckle interaction with the cBAF-type SWI/SNF complex. ARID1B depletion decreases binding of paraspeckle proteins to chromatin modifiers, transcription factors, and histones. Loss of ARID1B and NEAT1 affects transcription and alternative splicing of a common set of genes.","method":"Biochemical fractionation, RNA immunoprecipitation (RIP), mass spectrometry, RNA-seq, splicing analysis","journal":"EMBO reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding of NEAT1 to ARID1B shown by RIP, functional RNA-seq and splicing data, single lab","pmids":["36354291"],"is_preprint":false},{"year":2021,"finding":"Cytoplasmic mislocalization of ARID1B (via NLS mutation) abolishes canonical transcription activation and tumor suppressor functions but confers oncogenic gain-of-function. Cytoplasm-localized ARID1B binds c-RAF (RAF1) and PPP1CA, stimulating RAF-ERK signaling and β-catenin transcriptional activity. NLS-mutant ARID1B from tumor samples shows cytoplasmic localization and activates ERK signaling.","method":"In silico NLS prediction, fluorescence subcellular localization, cellular fractionation, co-immunoprecipitation (cytoplasmic ARID1B with c-RAF/PPP1CA), xenograft assays, immunohistochemistry on tissue microarray","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — subcellular localization with functional consequences, direct binding by co-IP, in vivo xenograft, single lab","pmids":["33443092"],"is_preprint":false},{"year":2021,"finding":"ARID1B knockdown in lung cancer cells increases DNA damage, impairs DNA repair, alters chromatin accessibility, and activates the cGAS-STING innate immune pathway.","method":"siRNA knockdown, γH2AX foci, ATAC-seq for chromatin accessibility, cGAS-STING pathway markers","journal":"Journal of Cancer","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, knockdown with pathway readout but limited mechanistic depth in abstract","pmids":["38577613"],"is_preprint":false},{"year":2021,"finding":"ARID1B acts as a molecular suppressor of erythropoiesis under hypoxia. ARID1B knockdown in non-CMS (non-chronic mountain sickness) cells increases GATA1 expression by 3-fold and RBC levels by 100-fold under hypoxia. ARID1B modulates chromatin accessibility at GATA1/p53 target genes and controls p53 levels and EPO sensitivity.","method":"iPSC model system, siRNA knockdown, GATA1/p53 quantification, ATAC-seq for chromatin accessibility, RBC differentiation assays","journal":"Experimental & molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ATAC-seq chromatin evidence combined with functional erythropoiesis assay and GATA1/p53 quantification, single lab","pmids":["35672450"],"is_preprint":false},{"year":2022,"finding":"The ARID domain of BAF250b (ARID1B) adopts a helix-turn-helix structure with a short β-sheet absent in its paralog BAF250a ARID. NMR chemical shift perturbations identified the DNA-binding interface of BAF250b ARID. Isothermal titration calorimetry showed moderate-affinity DNA binding with distinct thermodynamic signatures compared to BAF250a ARID.","method":"NMR backbone resonance assignment, backbone dynamics analysis, NMR chemical shift perturbations, HADDOCK structural modeling, isothermal titration calorimetry","journal":"Protein science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with functional DNA binding validation by ITC, single lab but two independent biophysical methods","pmids":["35481652"],"is_preprint":false},{"year":2022,"finding":"Early postnatal fluoxetine (SSRI) treatment in Arid1b+/- mice prevents synaptic and behavioral deficits in adults by normalizing HDAC4/MEF2A-related transcriptional regulation of SynGAP1 and Arc, and upregulating FMRP target genes. Arid1b haploinsufficiency causes persistent decreases in excitatory synaptic density and transmission.","method":"Fluoxetine treatment during postnatal weeks 1-3, electrophysiology (mEPSC), transcriptomic analysis (RNA-seq), behavioral assays","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological rescue with transcriptomic mechanism identified, single lab","pmids":["36030255"],"is_preprint":false},{"year":2023,"finding":"ARID1B blocks methionine-stimulated mTOR activation by binding to a specific region of the mTOR promoter and repressing mTOR transcription. Methionine reduces ARID1B binding to the mTOR promoter and decreases ARID1B protein levels via proteasomal degradation (MG132 but not chloroquine restores ARID1B). PI3K signaling mediates Met-induced reduction of ARID1B levels.","method":"ChIP for ARID1B at mTOR promoter, ARID1B knockdown/overactivation, mTOR reporter and protein phosphorylation assays, proteasome inhibitor experiments (MG132), cycloheximide chase","journal":"The Journal of nutritional biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP identifies direct promoter binding, proteasomal degradation mechanism established with multiple inhibitors, single lab","pmids":["36681308"],"is_preprint":false},{"year":2024,"finding":"Protein destabilization is the main mechanism by which pathogenic missense mutations in ARID1B cause Coffin-Siris syndrome, as demonstrated by saturated mutagenesis screens.","method":"Saturated mutagenesis screens (deep mutational scanning)","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — saturated/deep mutagenesis screen systematically establishing mechanism across all missense positions","pmids":["38347147"],"is_preprint":false},{"year":2024,"finding":"Pathogenic non-truncating ARID1B variants in the EHD2 and ARID domains cause protein misfolding and formation of cytoplasmic aggresomes surrounded by vimentin cage-like structures co-localizing with the MTOC. ARID domain variants also form nuclear aggregates. Protein levels are not reduced (NMD does not occur). The aggregation is attributed to exposure of amyloidogenic segments predicted by in silico structural analysis.","method":"Overexpression assays in cell lines, fluorescence microscopy (aggresome detection), quantitative western blot, in silico structural analysis, genome-wide transcriptome and methylation analysis","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct cellular imaging of protein aggregates, quantitative protein levels, structural prediction, single lab","pmids":["39028335"],"is_preprint":false},{"year":2024,"finding":"ARID1B loss in the GLI1+ mesenchymal stem cell (MSC) lineage disrupts MSC quiescence and promotes their proliferation via ectopic activation of non-canonical Activin signaling through p-ERK. ARID1B suppresses Bcl11b expression by binding directly to the third intron of Bcl11b. BCL11B, a BAF complex subunit, promotes non-canonical Activin signaling by regulating Inhba (activin A subunit) expression. Reducing Bcl11b or non-canonical Activin signaling rescues the MSC phenotype.","method":"scRNA-seq, scATAC-seq, mouse incisor Arid1b conditional KO model, ChIP for ARID1B at Bcl11b locus, genetic rescue (Bcl11b reduction), ERK phosphorylation analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — scRNA-seq plus scATAC-seq plus direct ChIP binding at Bcl11b intron plus genetic rescue, multiple orthogonal methods in vivo","pmids":["38816354"],"is_preprint":false},{"year":2024,"finding":"ARID1B controls chromatin accessibility at genomic regions targeted by TCF-like, NFI-like, and ARID-like transcription factors in callosal projection neurons expressing SATB2. In ARID1B+/- neural organoids, impaired SATB2+ neuron maturation and transcriptional dysregulation of corpus callosum development genes leads to defective long-range axonal projection formation.","method":"ARID1B+/- neural organoids, ATAC-seq for chromatin accessibility, RNA-seq, in vitro corpus callosum tract model for axonogenesis","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — ATAC-seq plus RNA-seq in human organoid model plus functional axonogenesis assay, multiple orthogonal methods","pmids":["38718796"],"is_preprint":false},{"year":2024,"finding":"mRNA display identified peptidic ligands that bind ARID1B with nanomolar affinity and high selectivity over ARID1A. Two distinct binding pockets were identified on ARID1B, one of which involves an ARID1B-exclusive cysteine residue that could allow covalent targeting.","method":"mRNA display (in vitro selection), biochemical binding assays, biophysical methods, chemical biology tools, competitive binding assays","journal":"ACS chemical biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding demonstrated with orthogonal methods, binding pockets mapped, single lab","pmids":["38655884"],"is_preprint":false},{"year":2023,"finding":"ARID1B nuclear import is mediated by the KPNA2-KPNB1-RANBP2 cascade. Mutations at ARID1B residues R1518, H1519, and D1522 (to T1518, G1519, G1522) attenuate ARID1B-KPNA2/KPNB1 interaction and prevent ARID1B recruitment to the nuclear pore complex. Pharmacological inhibition of KPNB1 suppresses ARID1B translocation to the nucleus. ARID1B negatively regulates ARID1A in the nucleus.","method":"Protein complex purification, mass spectrometry, site-directed mutagenesis, co-immunoprecipitation, KPNB1 inhibitor treatment, ARID1B KO mouse tumor models","journal":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mass spectrometry-identified complex, validated by co-IP and mutagenesis, single lab","pmids":["40671262"],"is_preprint":false}],"current_model":"ARID1B is the DNA-binding scaffolding subunit of the cBAF-type SWI/SNF chromatin remodeling complex, mutually exclusive with its paralog ARID1A, where it binds BRG1/SMARCA4 via its EHD2 domain, binds DNA via its ARID domain (NMR-defined interface), and is imported into the nucleus via the KPNA2-KPNB1-RANBP2 cascade; it represses Wnt/β-catenin signaling through BRG1 and β-catenin association, suppresses mTOR transcription by direct promoter binding, maintains mesenchymal stem cell quiescence by repressing Bcl11b-driven non-canonical Activin/ERK signaling, is required for NHEJ-based DNA repair, regulates cortical GABAergic interneuron development through H3K9 acetylation of the Pvalb promoter, and controls chromatin accessibility at enhancers governing pluripotency exit and axonal projection programs; its loss of function causes complex disassembly (ARID1B scaffolding loss disrupts not only cBAF but also pBAF), pathogenic missense mutations primarily act through protein destabilization or aggregation, and cytoplasmic mislocalization confers oncogenic gain-of-function via RAF-ERK activation."},"narrative":{"mechanistic_narrative":"ARID1B is the DNA-binding scaffolding subunit of cBAF-type SWI/SNF chromatin remodeling complexes, where it is mutually exclusive with its paralog ARID1A and controls chromatin accessibility programs governing proliferation, lineage transitions, and neuronal development [PMID:11988099, PMID:21647563, PMID:34753942]. It binds the ATPase BRG1/SMARCA4 through its EHD2 domain and engages DNA through its ARID domain, which adopts a helix-turn-helix fold with a paralog-distinct β-sheet and binds DNA with moderate affinity [PMID:11988099, PMID:35481652]. Within the cell cycle, ARID1B is expressed throughout all phases and is required for ES cell self-renewal, G1-to-S progression, and timely cell cycle re-entry, such that its loss delays proliferation [PMID:18323406, PMID:21647563, PMID:24674232]. ARID1B-BAF represses Wnt/β-catenin signaling by associating with β-catenin via its BRG1-binding domain, and this repression is central to its control of neurite outgrowth, chondro-/osteogenic bone growth, and neural progenitor behavior [PMID:26340334, PMID:31981384, PMID:33594090]. During differentiation, cells switch from ARID1A-BAF to ARID1B-BAF, attenuating NANOG/SOX2 enhancers to drive exit from pluripotency, and ARID1B shapes accessibility at enhancers controlling cortical interneuron, callosal projection neuron, and dendritic maturation programs—including H3K9 acetylation of the Pvalb promoter and c-Fos/Arc-dependent dendritic arborization [PMID:26937011, PMID:29184203, PMID:34753942, PMID:38718796]. ARID1B also represses mTOR transcription by direct promoter binding and maintains GLI1+ mesenchymal stem cell quiescence by directly repressing Bcl11b to suppress non-canonical Activin/p-ERK signaling [PMID:36681308, PMID:38816354]. ARID1B and ARID1A are interdependent for complex stability and NHEJ repair, and combined loss disrupts both cBAF and pBAF, making ARID1B a selective vulnerability in ARID1A-mutant cancers [PMID:24562383, PMID:24788099, PMID:34386776]. ARID1B nuclear import is driven by the KPNA2-KPNB1-RANBP2 and TNPO1 import machineries; NLS disruption mislocalizes ARID1B to the cytoplasm, where it binds c-RAF and PPP1CA to drive oncogenic RAF-ERK signaling [PMID:34044070, PMID:33443092, PMID:40671262]. Pathogenic missense variants causing Coffin-Siris syndrome act predominantly through protein destabilization and, for EHD2/ARID-domain variants, misfolding into cytoplasmic aggresomes [PMID:38347147, PMID:39028335].","teleology":[{"year":2002,"claim":"Established ARID1B's basic architecture as a SWI/SNF subunit, defining how it physically anchors to the remodeling complex and proposing its DNA-contacting module.","evidence":"Domain mapping and co-IP from brain extracts localizing BRG1 binding to the EHD2 domain and identifying the ARID domain","pmids":["11988099"],"confidence":"Medium","gaps":["DNA-binding activity of the ARID domain not demonstrated biochemically here","no structural detail of EHD2-BRG1 interface"]},{"year":2008,"claim":"Demonstrated that ARID1B-containing SWI/SNF is functionally required for stem cell self-renewal and cell cycle progression, moving beyond a structural role to cellular function.","evidence":"Biallelic inactivation in mouse ES cells with proliferation, self-renewal, and gene expression readouts","pmids":["18323406"],"confidence":"High","gaps":["direct chromatin targets driving the phenotype not identified","mechanism distinguishing ARID1B from ARID1A activity not addressed"]},{"year":2011,"claim":"Resolved how ARID1A and ARID1B are deployed differentially across the cell cycle, providing a basis for context-specific BAF assembly during proliferation versus arrest.","evidence":"Immunofluorescence and western blotting across synchronized cell cycle phases","pmids":["21647563"],"confidence":"Medium","gaps":["functional consequence of differential incorporation not tested","mechanism controlling mitotic ARID1A elimination unknown"]},{"year":2014,"claim":"Identified ARID1B as a synthetic-lethal vulnerability in ARID1A-mutant cancers and showed the paralogs are interdependent for complex stability and DNA double-strand break repair.","evidence":"shRNA/siRNA loss-of-function screens, complex stability assays, KU70/KU80 focus and clonogenic survival assays","pmids":["24562383","24788099"],"confidence":"High","gaps":["how residual complexes retain or lose specific functions not resolved","direct chromatin remodeling step at DSBs not biochemically reconstituted"]},{"year":2014,"claim":"Connected ARID1B dosage to disease-relevant cellular physiology by showing haploinsufficiency delays cell cycle re-entry in patient cells.","evidence":"BrdU/flow cytometry cell cycle analysis in patient-derived and knockdown fibroblasts","pmids":["24674232"],"confidence":"Medium","gaps":["molecular targets linking ARID1B loss to delayed re-entry not defined","single assay type"]},{"year":2015,"claim":"Defined a key signaling output of ARID1B-BAF: repression of Wnt/β-catenin through BRG1- and β-catenin-dependent mechanisms, with relevance to neurite outgrowth.","evidence":"Wnt reporter assays, endogenous/exogenous co-IP, BRG1-binding-domain deletion mutants, neurite outgrowth assays; cell cycle knockdown in breast cancer cells","pmids":["26340334","25817822"],"confidence":"High","gaps":["genomic Wnt target loci not mapped","whether repression occurs at chromatin or via β-catenin sequestration not distinguished"]},{"year":2016,"claim":"Placed ARID1B within a defined oncogenic pathway and a neuronal differentiation program, showing it acts downstream of STAT3/β-catenin and is required for proper dendritic and synaptic development.","evidence":"Insertional mutagenesis screen with conditional mouse models and ChIP (neurofibroma); in utero electroporation knockdown with morphology, electrophysiology, and c-Fos/Arc rescue (neurons)","pmids":["26904939","26937011"],"confidence":"High","gaps":["direct ARID1B chromatin targets in neurons not fully enumerated","how STAT3-driven repression of Arid1b is sustained not detailed"]},{"year":2017,"claim":"Provided in vivo mechanistic links between ARID1B haploinsufficiency and neurodevelopmental and growth phenotypes, including a specific histone-mark and promoter target.","evidence":"Arid1b heterozygous mice with cell counting, BrdU, H3K9ac ChIP at the Pvalb promoter, electrophysiology, and IGF1/GH measurement with GH rescue","pmids":["29184203","28695822"],"confidence":"High","gaps":["whether GABAergic and growth phenotypes share a common molecular target unknown","how ARID1B loss reduces global H3K9ac mechanistically not resolved"]},{"year":2020,"claim":"Revealed that ARID1B scaffolding loss disrupts both cBAF and pBAF and that paralog co-loss drives aggressive de-differentiated cancers, refining the synthetic-lethal model.","evidence":"Double-knockout mouse models, biochemical fractionation of SWI/SNF subcomplexes, scaffolding-domain mutations, senescence add-back assays; cell-type-specific interneuron conditional KOs with behavior","pmids":["34386776","32398858"],"confidence":"High","gaps":["mechanism by which residual cBAF subcomplexes poison pBAF not fully defined","which BAF target genes mediate senescence not pinpointed"]},{"year":2021,"claim":"Established ARID1B-BAF as a lineage-defining configuration that drives pluripotency exit and demonstrated its requirement for region-specific neurodevelopmental programs via β-catenin and chromatin accessibility.","evidence":"Patient iPSC multi-omics (ATAC-seq, ChIP-seq, RNA-seq, CUT&RUN) during cranial neural crest formation; conditional KO mouse models with β-catenin IF and behavior","pmids":["34753942","33594090"],"confidence":"High","gaps":["trigger initiating the ARID1A-to-ARID1B-BAF switch unknown","direct enhancer targets shared across lineages not unified"]},{"year":2021,"claim":"Expanded the regulatory and localization repertoire of ARID1B—nuclear import partners, paraspeckle/lncRNA association, erythropoietic suppression, and a cytoplasmic oncogenic gain-of-function.","evidence":"TNPO1 knockdown/co-IP with histone-mark ChIP and PI3K/AKT readouts; NEAT1 RIP and splicing RNA-seq; iPSC erythropoiesis with GATA1/p53 and ATAC-seq; NLS-mutant localization with c-RAF/PPP1CA co-IP and xenografts; cGAS-STING activation on knockdown","pmids":["34044070","36354291","35672450","33443092","38577613"],"confidence":"Medium","gaps":["how cytoplasmic ARID1B engages RAF-ERK independent of BAF not structurally defined","relationship between TNPO1 and KPNA2/KPNB1 import routes not reconciled","cGAS-STING link is low-confidence and lacks mechanistic depth"]},{"year":2022,"claim":"Provided the structural and biophysical basis for ARID1B DNA recognition and established paralog-distinguishing features of its ARID domain.","evidence":"NMR backbone assignment, chemical shift perturbation mapping, HADDOCK modeling, and ITC DNA-binding measurements; postnatal fluoxetine rescue of synaptic deficits with transcriptomic mechanism","pmids":["35481652","36030255"],"confidence":"High","gaps":["sequence specificity of ARID-domain DNA binding not defined","structure of full ARID1B or its EHD2-BRG1 interface unsolved"]},{"year":2023,"claim":"Defined transcriptional and metabolic control roles—direct mTOR promoter repression with nutrient-regulated degradation—and mapped the import cascade and ARID1B-ARID1A regulatory antagonism.","evidence":"ChIP at the mTOR promoter, proteasome-inhibitor and cycloheximide-chase experiments; mass-spectrometry complex purification with KPNA2/KPNB1/RANBP2 co-IP, mutagenesis, and KPNB1 inhibition","pmids":["36681308","40671262"],"confidence":"Medium","gaps":["whether mTOR promoter repression requires BAF remodeling not shown","physiological signals routing ARID1B to nuclear pores versus cytoplasm not integrated"]},{"year":2024,"claim":"Resolved how ARID1B controls adult stem cell quiescence and neuronal connectivity at the level of direct target genes and accessibility, while establishing that Coffin-Siris missense variants act through destabilization or aggregation.","evidence":"scRNA/scATAC-seq with ARID1B ChIP at the Bcl11b intron and genetic rescue (MSC); ARID1B+/- organoid ATAC-seq/RNA-seq with axonogenesis assays; deep mutational scanning; aggresome imaging with structural prediction; mRNA-display ligand discovery","pmids":["38816354","38718796","38347147","39028335","38655884"],"confidence":"High","gaps":["whether destabilizing and aggregating variants share downstream consequences not unified","selective peptidic ligands not yet shown to modulate ARID1B function in cells"]},{"year":null,"claim":"How a single ARID1B-BAF complex is directed to such diverse, context-specific gene programs—and how cytoplasmic gain-of-function, nuclear import routing, and variant-induced destabilization are mechanistically connected—remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["no full-length structure of ARID1B within assembled BAF","rules governing ARID1A-versus-ARID1B-BAF lineage switching unknown","no unified model linking cytoplasmic, import, and aggregation phenotypes"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,22]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[6,24,27]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[18]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[3,4,12]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,19,30]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[19,26]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[10,22]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[10,15,21,27,28]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[6,24,27]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[1,2,5,7]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[4]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,19,27]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[9,10,15,28]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[17,30]}],"complexes":["cBAF (SWI/SNF)","pBAF (SWI/SNF)"],"partners":["SMARCA4","ARID1A","CTNNB1","KPNA2","KPNB1","RANBP2","TNPO1","RAF1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8NFD5","full_name":"AT-rich interactive domain-containing protein 1B","aliases":["BRG1-associated factor 250b","BAF250B","BRG1-binding protein hELD/OSA1","Osa homolog 2","hOsa2","p250R"],"length_aa":2319,"mass_kda":243.9,"function":"Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Binds DNA non-specifically (PubMed:14982958, PubMed:15170388)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8NFD5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ARID1B","classification":"Not Classified","n_dependent_lines":55,"n_total_lines":1208,"dependency_fraction":0.04552980132450331},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000049618","cell_line_id":"CID001878","localizations":[{"compartment":"nucleoplasm","grade":3}],"interactors":[{"gene":"SMARCE1","stoichiometry":10.0},{"gene":"SMARCB1","stoichiometry":10.0},{"gene":"SMARCA4","stoichiometry":10.0},{"gene":"DPF2","stoichiometry":4.0},{"gene":"SMARCC1","stoichiometry":4.0},{"gene":"SMARCC2","stoichiometry":4.0},{"gene":"SMARCD1","stoichiometry":4.0},{"gene":"SMARCD2","stoichiometry":4.0},{"gene":"ACTB","stoichiometry":0.2},{"gene":"ACTG1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001878","total_profiled":1310},"omim":[{"mim_id":"615873","title":"HELSMOORTEL-VAN DER AA SYNDROME; HVDAS","url":"https://www.omim.org/entry/615873"},{"mim_id":"615866","title":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH MICROCEPHALY AND WITH OR WITHOUT OCULAR MALFORMATIONS OR HYPOGONADOTROPIC HYPOGONADISM; IDDMOH","url":"https://www.omim.org/entry/615866"},{"mim_id":"614556","title":"AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 1B; ARID1B","url":"https://www.omim.org/entry/614556"},{"mim_id":"611386","title":"ACTIVITY-DEPENDENT NEUROPROTECTOR HOMEOBOX; ADNP","url":"https://www.omim.org/entry/611386"},{"mim_id":"608025","title":"NBAS SUBUNIT OF NRZ TETHERING COMPLEX; NBAS","url":"https://www.omim.org/entry/608025"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Plasma membrane","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ARID1B"},"hgnc":{"alias_symbol":["KIAA1235","ELD/OSA1","p250R","BAF250b","DAN15","6A3-5","SMARCF2"],"prev_symbol":[]},"alphafold":{"accession":"Q8NFD5","domains":[{"cath_id":"1.10.150.60","chopping":"1046-1146","consensus_level":"high","plddt":84.9295,"start":1046,"end":1146},{"cath_id":"-","chopping":"1615-1698_1806-1819_1903-1909_1920-1978_2000-2051","consensus_level":"medium","plddt":93.2257,"start":1615,"end":2051},{"cath_id":"1.20.1050","chopping":"2124-2236","consensus_level":"medium","plddt":87.8832,"start":2124,"end":2236}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8NFD5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NFD5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NFD5-F1-predicted_aligned_error_v6.png","plddt_mean":46.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARID1B","jax_strain_url":"https://www.jax.org/strain/search?query=ARID1B"},"sequence":{"accession":"Q8NFD5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8NFD5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8NFD5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8NFD5"}},"corpus_meta":[{"pmid":"23202128","id":"PMC_23202128","title":"Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23202128","citation_count":344,"is_preprint":false},{"pmid":"24562383","id":"PMC_24562383","title":"ARID1B is a specific vulnerability in ARID1A-mutant cancers.","date":"2014","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24562383","citation_count":341,"is_preprint":false},{"pmid":"22426309","id":"PMC_22426309","title":"Mutations in SWI/SNF chromatin remodeling complex gene ARID1B cause Coffin-Siris syndrome.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22426309","citation_count":289,"is_preprint":false},{"pmid":"24788099","id":"PMC_24788099","title":"SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.","date":"2014","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24788099","citation_count":158,"is_preprint":false},{"pmid":"29184203","id":"PMC_29184203","title":"Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior.","date":"2017","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29184203","citation_count":146,"is_preprint":false},{"pmid":"18323406","id":"PMC_18323406","title":"BAF250B-associated SWI/SNF chromatin-remodeling complex is required to maintain undifferentiated mouse embryonic stem cells.","date":"2008","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/18323406","citation_count":141,"is_preprint":false},{"pmid":"21801163","id":"PMC_21801163","title":"Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B.","date":"2011","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21801163","citation_count":121,"is_preprint":false},{"pmid":"30349098","id":"PMC_30349098","title":"The ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin-Siris syndrome.","date":"2018","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30349098","citation_count":107,"is_preprint":false},{"pmid":"24382590","id":"PMC_24382590","title":"Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.","date":"2014","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24382590","citation_count":101,"is_preprint":false},{"pmid":"27562491","id":"PMC_27562491","title":"Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.","date":"2016","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/27562491","citation_count":94,"is_preprint":false},{"pmid":"28695822","id":"PMC_28695822","title":"Arid1b haploinsufficient mice reveal neuropsychiatric phenotypes and reversible causes of growth impairment.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28695822","citation_count":91,"is_preprint":false},{"pmid":"26340334","id":"PMC_26340334","title":"Chromatin-Remodeling-Factor ARID1B Represses Wnt/β-Catenin Signaling.","date":"2015","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26340334","citation_count":74,"is_preprint":false},{"pmid":"26937011","id":"PMC_26937011","title":"Essential Roles for ARID1B in Dendritic Arborization and Spine Morphology of Developing Pyramidal Neurons.","date":"2016","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26937011","citation_count":66,"is_preprint":false},{"pmid":"21647563","id":"PMC_21647563","title":"Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle.","date":"2011","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/21647563","citation_count":62,"is_preprint":false},{"pmid":"34512623","id":"PMC_34512623","title":"ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34512623","citation_count":58,"is_preprint":false},{"pmid":"9950359","id":"PMC_9950359","title":"Sex related expressivity of the phenotype in coronal craniosynostosis caused by the recurrent P250R FGFR3 mutation.","date":"1999","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9950359","citation_count":56,"is_preprint":false},{"pmid":"26904939","id":"PMC_26904939","title":"Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26904939","citation_count":55,"is_preprint":false},{"pmid":"27392123","id":"PMC_27392123","title":"Frequency and outcome of pediatric acute lymphoblastic leukemia with ZNF384 gene rearrangements including a novel translocation resulting in an ARID1B/ZNF384 gene fusion.","date":"2016","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27392123","citation_count":54,"is_preprint":false},{"pmid":"23660946","id":"PMC_23660946","title":"ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines.","date":"2013","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23660946","citation_count":52,"is_preprint":false},{"pmid":"34386776","id":"PMC_34386776","title":"Dual ARID1A/ARID1B loss leads to rapid carcinogenesis and disruptive redistribution of BAF complexes.","date":"2020","source":"Nature cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34386776","citation_count":51,"is_preprint":false},{"pmid":"15915095","id":"PMC_15915095","title":"FGFR3 P250R mutation increases the risk of reoperation in apparent 'nonsyndromic' coronal craniosynostosis.","date":"2005","source":"The Journal of craniofacial surgery","url":"https://pubmed.ncbi.nlm.nih.gov/15915095","citation_count":43,"is_preprint":false},{"pmid":"33686214","id":"PMC_33686214","title":"Neurobiology of ARID1B haploinsufficiency related to neurodevelopmental and psychiatric disorders.","date":"2021","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/33686214","citation_count":40,"is_preprint":false},{"pmid":"11988099","id":"PMC_11988099","title":"Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein.","date":"2002","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11988099","citation_count":36,"is_preprint":false},{"pmid":"9279764","id":"PMC_9279764","title":"Phenotypic expression of the fibroblast growth factor receptor 3 (FGFR3) mutation P250R in a large craniosynostosis family.","date":"1997","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9279764","citation_count":35,"is_preprint":false},{"pmid":"28877054","id":"PMC_28877054","title":"Melanotic Translocation Renal Cell Carcinoma With a Novel ARID1B-TFE3 Gene Fusion.","date":"2017","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28877054","citation_count":35,"is_preprint":false},{"pmid":"25674384","id":"PMC_25674384","title":"ARID1B-mediated disorders: Mutations and possible mechanisms.","date":"2015","source":"Intractable & rare diseases research","url":"https://pubmed.ncbi.nlm.nih.gov/25674384","citation_count":34,"is_preprint":false},{"pmid":"30260819","id":"PMC_30260819","title":"Serum miRNA expression profiling reveals miR-486-3p may play a significant role in the development of autism by targeting ARID1B.","date":"2018","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/30260819","citation_count":34,"is_preprint":false},{"pmid":"38718796","id":"PMC_38718796","title":"ARID1B controls transcriptional programs of axon projection in an organoid model of the human corpus callosum.","date":"2024","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/38718796","citation_count":33,"is_preprint":false},{"pmid":"31796878","id":"PMC_31796878","title":"Targeting ARID1A-mutant colorectal cancer: depletion of ARID1B increases radiosensitivity and modulates DNA damage response.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31796878","citation_count":30,"is_preprint":false},{"pmid":"24649241","id":"PMC_24649241","title":"Jumonji/Arid1b (Jarid1b) protein modulates human esophageal cancer cell growth.","date":"2013","source":"Molecular and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24649241","citation_count":30,"is_preprint":false},{"pmid":"26637902","id":"PMC_26637902","title":"Loss of ARID1A, ARID1B, and ARID2 Expression During Progression of Gastric Cancer.","date":"2015","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/26637902","citation_count":29,"is_preprint":false},{"pmid":"34753942","id":"PMC_34753942","title":"Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disorders.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34753942","citation_count":28,"is_preprint":false},{"pmid":"33748136","id":"PMC_33748136","title":"The Evolutionary Conserved SWI/SNF Subunits ARID1A and ARID1B Are Key Modulators of Pluripotency and Cell-Fate Determination.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33748136","citation_count":27,"is_preprint":false},{"pmid":"26376624","id":"PMC_26376624","title":"De novo mutations in ARID1B associated with both syndromic and non-syndromic short stature.","date":"2015","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/26376624","citation_count":27,"is_preprint":false},{"pmid":"33757588","id":"PMC_33757588","title":"Neuroanatomy and behavior in mice with a haploinsufficiency of AT-rich interactive domain 1B (ARID1B) throughout development.","date":"2021","source":"Molecular autism","url":"https://pubmed.ncbi.nlm.nih.gov/33757588","citation_count":26,"is_preprint":false},{"pmid":"30149092","id":"PMC_30149092","title":"The role of ARID1B, a BAF chromatin remodeling complex subunit, in neural development and behavior.","date":"2018","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30149092","citation_count":24,"is_preprint":false},{"pmid":"36354291","id":"PMC_36354291","title":"Paraspeckles interact with SWI/SNF subunit ARID1B to regulate transcription and splicing.","date":"2022","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/36354291","citation_count":24,"is_preprint":false},{"pmid":"32398858","id":"PMC_32398858","title":"Arid1b haploinsufficiency in parvalbumin- or somatostatin-expressing interneurons leads to distinct ASD-like and ID-like behavior.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32398858","citation_count":24,"is_preprint":false},{"pmid":"33262327","id":"PMC_33262327","title":"Autism-associated miR-873 regulates ARID1B, SHANK3 and NRXN2 involved in neurodevelopment.","date":"2020","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/33262327","citation_count":24,"is_preprint":false},{"pmid":"31981384","id":"PMC_31981384","title":"De Novo ARID1B mutations cause growth delay associated with aberrant Wnt/β-catenin signaling.","date":"2020","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/31981384","citation_count":23,"is_preprint":false},{"pmid":"29890703","id":"PMC_29890703","title":"ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29890703","citation_count":23,"is_preprint":false},{"pmid":"28521285","id":"PMC_28521285","title":"ARID1B alterations identify aggressive tumors in neuroblastoma.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28521285","citation_count":22,"is_preprint":false},{"pmid":"32910019","id":"PMC_32910019","title":"BRG1, INI1, and ARID1B Deficiency in Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Analysis of a Large Series From a Single Institution.","date":"2020","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32910019","citation_count":20,"is_preprint":false},{"pmid":"11424131","id":"PMC_11424131","title":"Premature calvarial synostosis and epidermal hyperplasia (Beare-Stevenson syndrome-like anomalies) resulting from a P250R missense mutation in the gene encoding fibroblast growth factor receptor 3.","date":"2001","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11424131","citation_count":20,"is_preprint":false},{"pmid":"25817822","id":"PMC_25817822","title":"Clinicopathological significance of ARID1B in breast invasive ductal carcinoma.","date":"2015","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/25817822","citation_count":19,"is_preprint":false},{"pmid":"24674232","id":"PMC_24674232","title":"Expanding the phenotypic spectrum of ARID1B-mediated disorders and identification of altered cell-cycle dynamics due to ARID1B haploinsufficiency.","date":"2014","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24674232","citation_count":19,"is_preprint":false},{"pmid":"24569609","id":"PMC_24569609","title":"Coffin-Siris Syndrome with obesity, macrocephaly, hepatomegaly and hyperinsulinism caused by a mutation in the ARID1B gene.","date":"2014","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/24569609","citation_count":19,"is_preprint":false},{"pmid":"33683826","id":"PMC_33683826","title":"ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33683826","citation_count":18,"is_preprint":false},{"pmid":"29151933","id":"PMC_29151933","title":"Expression of ARID1B Is Associated With Poor Outcomes and Predicts the Benefit from Adjuvant Chemotherapy in Bladder Urothelial Carcinoma.","date":"2017","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29151933","citation_count":18,"is_preprint":false},{"pmid":"26754677","id":"PMC_26754677","title":"Interstitial 6q25 microdeletion syndrome: ARID1B is the key gene.","date":"2016","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/26754677","citation_count":18,"is_preprint":false},{"pmid":"33594090","id":"PMC_33594090","title":"Differential roles of ARID1B in excitatory and inhibitory neural progenitors in the developing cortex.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33594090","citation_count":17,"is_preprint":false},{"pmid":"27511161","id":"PMC_27511161","title":"Hirschsprung disease as a yet undescribed phenotype in a patient with ARID1B mutation.","date":"2016","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/27511161","citation_count":17,"is_preprint":false},{"pmid":"27570168","id":"PMC_27570168","title":"A novel familial autosomal dominant mutation in ARID1B causing neurodevelopmental delays, short stature, and dysmorphic features.","date":"2016","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/27570168","citation_count":16,"is_preprint":false},{"pmid":"38577613","id":"PMC_38577613","title":"ARID1B Deficiency Leads to Impaired DNA Damage Response and Activated cGAS-STING Pathway in Non-Small Cell Lung Cancer.","date":"2024","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/38577613","citation_count":15,"is_preprint":false},{"pmid":"33432679","id":"PMC_33432679","title":"Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.","date":"2021","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/33432679","citation_count":15,"is_preprint":false},{"pmid":"35672450","id":"PMC_35672450","title":"ARID1B, a molecular suppressor of erythropoiesis, is essential for the prevention of Monge's disease.","date":"2022","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35672450","citation_count":14,"is_preprint":false},{"pmid":"36030255","id":"PMC_36030255","title":"Early postnatal serotonin modulation prevents adult-stage deficits in Arid1b-deficient mice through synaptic transcriptional reprogramming.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36030255","citation_count":14,"is_preprint":false},{"pmid":"26395437","id":"PMC_26395437","title":"Gonadal mosaicism in ARID1B gene causes intellectual disability and dysmorphic features in three siblings.","date":"2015","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/26395437","citation_count":14,"is_preprint":false},{"pmid":"25250687","id":"PMC_25250687","title":"Disruption of the ARID1B and ADAMTS6 loci due to a t(5;6)(q12.3;q25.3) in a patient with developmental delay.","date":"2014","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/25250687","citation_count":13,"is_preprint":false},{"pmid":"27672547","id":"PMC_27672547","title":"Coffin-Siris syndrome with café-au-lait spots, obesity and hyperinsulinism caused by a mutation in the ARID1B gene.","date":"2016","source":"Intractable & rare diseases research","url":"https://pubmed.ncbi.nlm.nih.gov/27672547","citation_count":12,"is_preprint":false},{"pmid":"34044070","id":"PMC_34044070","title":"TNPO1-mediated nuclear import of ARID1B promotes tumor growth in ARID1A-deficient gynecologic cancer.","date":"2021","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/34044070","citation_count":11,"is_preprint":false},{"pmid":"34440449","id":"PMC_34440449","title":"A Case Series of Familial ARID1B Variants Illustrating Variable Expression and Suggestions to Update the ACMG Criteria.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34440449","citation_count":11,"is_preprint":false},{"pmid":"33443092","id":"PMC_33443092","title":"Aberrant cytoplasmic localization of ARID1B activates ERK signaling and promotes oncogenesis.","date":"2021","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/33443092","citation_count":10,"is_preprint":false},{"pmid":"38347147","id":"PMC_38347147","title":"Protein destabilization underlies pathogenic missense mutations in ARID1B.","date":"2024","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/38347147","citation_count":10,"is_preprint":false},{"pmid":"39536425","id":"PMC_39536425","title":"Mutations of ARID1B, PIK3C2B, KMT2B, and FAT1 genes influence clinical outcome in newly diagnosed myeloma.","date":"2024","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39536425","citation_count":9,"is_preprint":false},{"pmid":"36681308","id":"PMC_36681308","title":"ARID1B blocks methionine-stimulated mTOR activation to inhibit milk fat and protein synthesis in and proliferation of mouse mammary epithelial cells.","date":"2023","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36681308","citation_count":9,"is_preprint":false},{"pmid":"31628733","id":"PMC_31628733","title":"De novo splice site variant of ARID1B associated with pathogenesis of Coffin-Siris syndrome.","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31628733","citation_count":9,"is_preprint":false},{"pmid":"17103449","id":"PMC_17103449","title":"Sudden infant death in a patient with FGFR3 P250R mutation.","date":"2006","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/17103449","citation_count":9,"is_preprint":false},{"pmid":"37287661","id":"PMC_37287661","title":"Pleiotropic effects of a high confidence Autism Spectrum Disorder gene, arid1b, on zebrafish sleep.","date":"2023","source":"Neurobiology of sleep and circadian rhythms","url":"https://pubmed.ncbi.nlm.nih.gov/37287661","citation_count":8,"is_preprint":false},{"pmid":"35481652","id":"PMC_35481652","title":"Structure and DNA binding analysis of AT-rich interaction domain present in human BAF-B specific subunit BAF250b.","date":"2022","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/35481652","citation_count":7,"is_preprint":false},{"pmid":"31421289","id":"PMC_31421289","title":"Striking phenotypic overlap between Nicolaides-Baraitser and Coffin-Siris syndromes in monozygotic twins with ARID1B intragenic deletion.","date":"2019","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31421289","citation_count":7,"is_preprint":false},{"pmid":"28691782","id":"PMC_28691782","title":"A novel microduplication of ARID1B: Clinical, genetic, and proteomic findings.","date":"2017","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/28691782","citation_count":7,"is_preprint":false},{"pmid":"38816354","id":"PMC_38816354","title":"ARID1B maintains mesenchymal stem cell quiescence via inhibition of BCL11B-mediated non-canonical Activin signaling.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38816354","citation_count":6,"is_preprint":false},{"pmid":"35879281","id":"PMC_35879281","title":"A novel nonsense variant in ARID1B causing simultaneous RNA decay and exon skipping is associated with Coffin-Siris syndrome.","date":"2022","source":"Human genome variation","url":"https://pubmed.ncbi.nlm.nih.gov/35879281","citation_count":6,"is_preprint":false},{"pmid":"33949667","id":"PMC_33949667","title":"Downregulation of ARID1B, a tumor suppressor in the WNT subgroup medulloblastoma, activates multiple oncogenic signaling pathways.","date":"2021","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33949667","citation_count":6,"is_preprint":false},{"pmid":"37387408","id":"PMC_37387408","title":"Acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia accompanying ARID1B gene mutation.","date":"2023","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/37387408","citation_count":5,"is_preprint":false},{"pmid":"28415691","id":"PMC_28415691","title":"A potentially functional variant of ARID1B interacts with physical activity in association with risk of hepatocellular carcinoma.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28415691","citation_count":5,"is_preprint":false},{"pmid":"32618029","id":"PMC_32618029","title":"Coffin-Siris syndrome with bilateral macular dysplasia caused by a novel exonic deletion in ARID1B.","date":"2020","source":"Congenital anomalies","url":"https://pubmed.ncbi.nlm.nih.gov/32618029","citation_count":5,"is_preprint":false},{"pmid":"39355979","id":"PMC_39355979","title":"Microduplications of ARID1A and ARID1B cause a novel clinical and epigenetic distinct BAFopathy.","date":"2024","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39355979","citation_count":4,"is_preprint":false},{"pmid":"34730517","id":"PMC_34730517","title":"Epilepsy features in ARID1B-related Coffin-Siris syndrome.","date":"2021","source":"Epileptic disorders : international epilepsy journal with videotape","url":"https://pubmed.ncbi.nlm.nih.gov/34730517","citation_count":4,"is_preprint":false},{"pmid":"37611161","id":"PMC_37611161","title":"Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis.","date":"2023","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/37611161","citation_count":4,"is_preprint":false},{"pmid":"36313455","id":"PMC_36313455","title":"Aberrantly hypermethylated ARID1B is a novel biomarker and potential therapeutic target of colon adenocarcinoma.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36313455","citation_count":4,"is_preprint":false},{"pmid":"39028335","id":"PMC_39028335","title":"The missing link: ARID1B non-truncating variants causing Coffin-Siris syndrome due to protein aggregation.","date":"2024","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39028335","citation_count":4,"is_preprint":false},{"pmid":"36352633","id":"PMC_36352633","title":"Three Novel ARID1B Variations in Coffin-Siris Syndrome Patients.","date":"2022","source":"Neurology India","url":"https://pubmed.ncbi.nlm.nih.gov/36352633","citation_count":4,"is_preprint":false},{"pmid":"37654076","id":"PMC_37654076","title":"Integration of EpiSign, facial phenotyping, and likelihood ratio interpretation of clinical abnormalities in the re-classification of an ARID1B missense variant.","date":"2023","source":"American journal of medical genetics. Part C, Seminars in medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37654076","citation_count":4,"is_preprint":false},{"pmid":"32339967","id":"PMC_32339967","title":"Coffin-Siris Syndrome-1: Report of five cases from Asian populations with truncating mutations in the ARID1B gene.","date":"2020","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32339967","citation_count":4,"is_preprint":false},{"pmid":"32161024","id":"PMC_32161024","title":"First Korean Case of Coffin-Siris Syndrome with a Novel Frameshift ARID1B Mutation.","date":"2020","source":"Annals of clinical and laboratory science","url":"https://pubmed.ncbi.nlm.nih.gov/32161024","citation_count":4,"is_preprint":false},{"pmid":"37556934","id":"PMC_37556934","title":"Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.","date":"2023","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37556934","citation_count":3,"is_preprint":false},{"pmid":"36843546","id":"PMC_36843546","title":"Dedifferentiated Ovarian Carcinoma with ARID1A and ARID1B Mutations: A Clinicopathological Report and Literature Review.","date":"2023","source":"International journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/36843546","citation_count":3,"is_preprint":false},{"pmid":"33936271","id":"PMC_33936271","title":"Novel ARID1B variant inherited from somatogonadal mosaic mother in siblings with Coffin-Siris syndrome 1.","date":"2021","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33936271","citation_count":3,"is_preprint":false},{"pmid":"38790056","id":"PMC_38790056","title":"De novo variation in ARID1B gene causes Coffin-Siris syndrome 1 in a Chinese family with excessive early-onset high myopia.","date":"2024","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/38790056","citation_count":3,"is_preprint":false},{"pmid":"32682288","id":"PMC_32682288","title":"CRISPR/Cas9 mediated generation of human ARID1B heterozygous knockout hESC lines to model Coffin-Siris syndrome.","date":"2020","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/32682288","citation_count":3,"is_preprint":false},{"pmid":"38655884","id":"PMC_38655884","title":"mRNA Display Identifies Potent, Paralog-Selective Peptidic Ligands for ARID1B.","date":"2024","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/38655884","citation_count":2,"is_preprint":false},{"pmid":"37686505","id":"PMC_37686505","title":"ARID1B Immunohistochemistry Is an Important Test for the Diagnosis of Dedifferentiated and Undifferentiated Gynecologic Malignancies.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/37686505","citation_count":2,"is_preprint":false},{"pmid":"36588753","id":"PMC_36588753","title":"Growth Hormone Deficiency due to p.(Gln467Argfs*64) Mutation in the ARID1B Gene in a Girl with Coffin-Siris Syndrome.","date":"2022","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/36588753","citation_count":2,"is_preprint":false},{"pmid":"39446840","id":"PMC_39446840","title":"The SWI/SNF subunit ARID1B is important for regenerative ability of hematopoietic stem cells in normal hematopoiesis.","date":"2024","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/39446840","citation_count":2,"is_preprint":false},{"pmid":"35964110","id":"PMC_35964110","title":"Short stature and melanocytic nevi in a girl with ARID1B-related Coffin-Siris syndrome: a case report.","date":"2022","source":"BMC pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/35964110","citation_count":2,"is_preprint":false},{"pmid":"34620277","id":"PMC_34620277","title":"The molecular mechanism of the transcriptional activator SWI regulating gene ARID1B affecting swallowing dysfunction after stroke in rats.","date":"2021","source":"Die Pharmazie","url":"https://pubmed.ncbi.nlm.nih.gov/34620277","citation_count":2,"is_preprint":false},{"pmid":"40671262","id":"PMC_40671262","title":"Disruption of ARID1B Recruitment to the Nuclear Pore Complex as a New Anticancer Therapeutic Strategy.","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/40671262","citation_count":1,"is_preprint":false},{"pmid":"41000613","id":"PMC_41000613","title":"ARID1A and ARID1B preserve B cell identity, prevent myeloid transformation and reveal therapeutic vulnerabilities.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41000613","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48440,"output_tokens":8130,"usd":0.133635,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17775,"output_tokens":5518,"usd":0.113412,"stage2_stop_reason":"end_turn"},"total_usd":0.247047,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"ARID1B (hELD/OSA1) was cloned as a human homolog of Drosophila Eld/Osa and shown to be a component of endogenous SWI/SNF complexes. The EHD2 domain of ARID1B mediates direct binding to BRG1 (SMARCA4), the ATPase subunit of SWI/SNF. EHD1 and EHD2 domains can also interact with each other. An ARID domain was identified as a putative DNA-binding domain.\",\n      \"method\": \"Domain mapping, co-immunoprecipitation from mouse brain extracts, antibody against EHD2\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding interaction mapped by domain co-IP, single lab, two orthogonal methods (co-IP + domain deletion)\",\n      \"pmids\": [\"11988099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BAF250B (ARID1B)-containing SWI/SNF complex is required for mouse embryonic stem cell self-renewal and normal cell cycle progression. Biallelic inactivation of BAF250B in ES cells reduced proliferation, impaired self-renewal, and altered expression of pluripotency and differentiation genes.\",\n      \"method\": \"Biallelic gene inactivation in mouse ES cells, proliferation assays, gene expression analysis, cell cycle analysis\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout with defined cellular phenotype, multiple orthogonal readouts (cell cycle, pluripotency gene expression, self-renewal assay)\",\n      \"pmids\": [\"18323406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ARID1A and ARID1B are mutually exclusive subunits of the BAF complex with different cell-cycle expression kinetics: ARID1A accumulates in G0 and is eliminated during mitosis, whereas ARID1B is expressed at comparable levels throughout all cell cycle phases including mitosis, suggesting differential incorporation into SWI/SNF during proliferation versus arrest.\",\n      \"method\": \"Immunofluorescence, western blotting across synchronized cell cycle phases, expression analysis in mouse embryos\",\n      \"journal\": \"Cell and tissue research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization and protein-level cell cycle analysis, single lab, two methods\",\n      \"pmids\": [\"21647563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ARID1B is a specific vulnerability in ARID1A-mutant cancers. ARID1B is the paralog that is mutually exclusive with ARID1A in SWI/SNF (cBAF) complexes. Loss of ARID1B in an ARID1A-deficient background destabilizes the SWI/SNF complex and impairs proliferation in cancer cells and primary cells.\",\n      \"method\": \"Broad siRNA/shRNA screening, genetic loss-of-function in cancer cell lines, protein complex stability assays (co-IP/western blot), proliferation assays\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic screening plus mechanistic validation (complex stability, proliferation), replicated across multiple cell lines\",\n      \"pmids\": [\"24562383\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Both ARID1A and ARID1B are required for efficient non-homologous end joining (NHEJ) of DNA double-strand breaks. Suppression of either protein reduces KU70/KU80 accumulation at DSBs and sensitizes cells to ionizing radiation, cisplatin, and UV. Both ARID1 proteins facilitate recruitment of the SWI/SNF ATPase subunit to DSBs. ARID1A and ARID1B show interdependent protein stability within the complex.\",\n      \"method\": \"siRNA knockdown, live-cell imaging of DSB repair, KU70/KU80 focus assays, clonogenic survival, co-immunoprecipitation\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (live imaging, focus assays, survival assays, co-IP), single lab with rigorous controls\",\n      \"pmids\": [\"24788099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ARID1B haploinsufficiency in patient-derived fibroblasts causes delayed cell cycle re-entry after serum starvation, with reduced cell numbers in S phase, providing direct evidence that altered cell cycle dynamics underlie ARID1B-associated disorders.\",\n      \"method\": \"Cell cycle analysis (BrdU/flow cytometry) in patient-derived and ARID1B knockdown fibroblasts after serum starvation\",\n      \"journal\": \"Orphanet journal of rare diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient-derived cells plus knockdown model, single lab, single assay type\",\n      \"pmids\": [\"24674232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ARID1B is a repressor of Wnt/β-catenin signaling. Knockdown of ARID1B activates Wnt/β-catenin target genes and transcriptional reporters in a β-catenin-dependent manner. Endogenous and exogenous ARID1B associate with β-catenin. ARID1B represses Wnt/β-catenin-mediated transcription through the BAF core subunit BRG1. Mutations in ARID1B that delete its BRG1-binding domain compromise association with β-catenin and fail to suppress Wnt signaling. ARID1B knockdown in mouse neuroblastoma cells promotes neurite outgrowth through β-catenin.\",\n      \"method\": \"Transcriptome analysis, Wnt reporter assays, siRNA knockdown, co-immunoprecipitation (endogenous and exogenous), domain-deletion mutagenesis, neurite outgrowth assay\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (co-IP, reporter assay, mutagenesis, transcriptome, cellular phenotype), single lab\",\n      \"pmids\": [\"26340334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ARID1B knockdown in breast cancer cells (MDA-MB-231) causes delay in G1-to-S phase cell cycle transition and decreased cell proliferation, establishing a direct role for ARID1B in cell cycle progression.\",\n      \"method\": \"siRNA knockdown, flow cytometry cell cycle analysis, proliferation assay\",\n      \"journal\": \"Histopathology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single knockdown experiment with cell cycle readout, limited mechanistic depth\",\n      \"pmids\": [\"25817822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"P-STAT3 represses Arid1b expression through BRG1-dependent histone modification, leading to increased β-catenin activity in Schwann cell progenitors. Arid1b acts downstream of STAT3 as part of an Nf1-Stat3-Arid1b/β-catenin neurofibroma initiation pathway. Knockdown of Arid1b rescues neurofibroma formation in Stat3-deficient SCPs after in vivo transplantation.\",\n      \"method\": \"Insertional mutagenesis screen, mouse genetic models (conditional knockouts), ChIP for histone marks, in vivo transplantation, genetic epistasis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis via genetic models, mechanistic ChIP data, in vivo transplantation rescue, multiple orthogonal approaches\",\n      \"pmids\": [\"26904939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ARID1B is required for dendritic arborization and spine morphology of developing pyramidal neurons. ARID1B knockdown suppresses dendritic arborization of cortical and hippocampal pyramidal neurons, causes aberrant dendritic spines and impaired synaptic transmission, and reduces expression of c-Fos and Arc; overexpression of c-Fos and Arc rescues the dendritic differentiation defects.\",\n      \"method\": \"In utero electroporation-mediated knockdown, confocal imaging of dendritic morphology, electrophysiology, gene expression analysis, rescue experiments with c-Fos/Arc overexpression\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in utero knockdown with morphological and electrophysiological readouts plus genetic rescue, multiple orthogonal methods\",\n      \"pmids\": [\"26937011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Arid1b haploinsufficiency in mice reduces cortical GABAergic interneuron numbers and proliferation of interneuron progenitors in the ganglionic eminence, leads to E/I synaptic imbalance in the cerebral cortex, and suppresses H3K9 acetylation globally and specifically at the Pvalb promoter, resulting in decreased parvalbumin transcription.\",\n      \"method\": \"Arid1b knockout mouse model (heterozygotes), cell counting, BrdU proliferation assay, ChIP for H3K9ac, qRT-PCR, synaptic electrophysiology\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (ChIP, electrophysiology, cell counting, BrdU), validated in mouse model with defined molecular mechanism\",\n      \"pmids\": [\"29184203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Arid1b haploinsufficiency in mice causes IGF1 deficiency with inadequate GHRH/GH compensation, leading to growth retardation and muscle weakness. GH supplementation corrects growth retardation but not behavioral abnormalities. Arid1b haploinsufficiency alters expression of SWI/SNF-regulated genes implicated in neuropsychiatric disorders.\",\n      \"method\": \"Arid1b heterozygous mouse model, serum IGF1/GH measurements, GH supplementation rescue, gene expression analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mouse model with hormonal measurements and rescue experiment, single lab\",\n      \"pmids\": [\"28695822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Dual loss of ARID1A and ARID1B causes aggressive carcinogenesis through de-differentiation and hyperproliferation in liver and skin. Residual cBAF subcomplexes from loss of ARID1 scaffolding unexpectedly disrupt polybromo-containing pBAF function. Mutations in conserved scaffolding domains of ARID1 proteins cause complex disassembly. In double-mutant endometrial cancer cells, add-back of either ARID1A or ARID1B induced senescence.\",\n      \"method\": \"Double-knockout mouse models (liver, skin), endometrial cancer cell lines, biochemical fractionation of SWI/SNF subcomplexes, domain mutation analysis, senescence assays\",\n      \"journal\": \"Nature cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo double-KO models, biochemical complex analysis, cell-based rescue, multiple orthogonal approaches\",\n      \"pmids\": [\"34386776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Arid1b haploinsufficiency in parvalbumin (PV) interneurons causes social and emotional impairments, while deletion in somatostatin (SST) interneurons causes stereotypies and learning/memory dysfunction, demonstrating interneuron subtype-specific contributions to ARID1B-associated behavioral phenotypes.\",\n      \"method\": \"Cell-type-specific conditional Arid1b knockout mice (PV-Cre and SST-Cre), behavioral testing\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with cell-type specificity and behavioral readouts, single lab\",\n      \"pmids\": [\"32398858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Arid1b deficiency in zebrafish embryos reduces body length and perturbs expression of chondrogenic and osteogenic genes (sox9a, col2a1a, runx2b, col10a1). Knockout of Arid1b in chondrogenic ATDC5 cells inhibits chondrocyte proliferation and differentiation. Wnt/β-catenin signaling is perturbed in Arid1b-depleted zebrafish and Arid1b-KO ATDC5 cells, linking ARID1B to bone growth via Wnt/β-catenin regulation.\",\n      \"method\": \"Zebrafish arid1b morpholino knockdown, Arid1b KO in ATDC5 cells, qRT-PCR for osteogenic genes, Wnt reporter assays, proliferation/differentiation assays\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two model systems (zebrafish, cell line), pathway (Wnt) validation, single lab\",\n      \"pmids\": [\"31981384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ARID1B is present only during the neuroectoderm specification stage of cranial neural crest cell formation and is part of a lineage-specific ARID1B-BAF configuration. At the onset of differentiation, cells transition from ARID1A-BAF to ARID1B-BAF, which attenuates NANOG and SOX2 network enhancers and genes to drive exit from pluripotency. In ARID1B+/- patient iPSCs, this ARID1A-to-ARID1B-BAF switch fails, maintaining NANOG/SOX2 activity and impairing neural crest formation.\",\n      \"method\": \"Patient-derived iPSCs (ARID1B+/-), ATAC-seq, ChIP-seq, RNA-seq, CUT&RUN for BAF subunits during CNCC differentiation\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple genomic methods (ATAC-seq, ChIP-seq, RNA-seq) in patient iPSCs with mechanistic pathway identification, single lab but rigorous multi-omic approach\",\n      \"pmids\": [\"34753942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ARID1B deletion in ventral (inhibitory) neural progenitors decreases proliferation, alters cell cycle regulation, increases cell death, and decreases nuclear β-catenin localization in Arid1b-deficient neurons. Conditional homozygous deletion of Arid1b in ventral neural progenitors produces pronounced ID- and ASD-like behaviors, whereas deletion in cortical progenitors produces only minor cognitive deficits.\",\n      \"method\": \"Conditional and global Arid1b KO mouse models, BrdU proliferation assays, TUNEL apoptosis, immunofluorescence for β-catenin localization, behavioral testing\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with cell-type specificity, subcellular localization by IF, behavioral phenotype, single lab\",\n      \"pmids\": [\"33594090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TNPO1 mediates nuclear import of ARID1B. In ARID1A-deficient gynecologic cancer cells, TNPO1 knockdown phenocopies ARID1B knockdown. TNPO1 or ARID1B knockdown reduces H3K4me1 and H3K27ac marks, decreases AP-1 family transcription factor binding, and inactivates PI3K/AKT signaling by reducing PIK3CA and FGFR2 expression.\",\n      \"method\": \"Gene expression profiling, siRNA knockdown, Co-IP, chromatin accessibility assays (ATAC-seq), ChIP for histone marks, in vitro and in vivo tumor growth assays\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — nuclear import mechanism identified by knockdown and co-IP, chromatin changes validated, single lab\",\n      \"pmids\": [\"34044070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ARID1B directly interacts with the lncRNA NEAT1 of paraspeckles, mediating paraspeckle interaction with the cBAF-type SWI/SNF complex. ARID1B depletion decreases binding of paraspeckle proteins to chromatin modifiers, transcription factors, and histones. Loss of ARID1B and NEAT1 affects transcription and alternative splicing of a common set of genes.\",\n      \"method\": \"Biochemical fractionation, RNA immunoprecipitation (RIP), mass spectrometry, RNA-seq, splicing analysis\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding of NEAT1 to ARID1B shown by RIP, functional RNA-seq and splicing data, single lab\",\n      \"pmids\": [\"36354291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cytoplasmic mislocalization of ARID1B (via NLS mutation) abolishes canonical transcription activation and tumor suppressor functions but confers oncogenic gain-of-function. Cytoplasm-localized ARID1B binds c-RAF (RAF1) and PPP1CA, stimulating RAF-ERK signaling and β-catenin transcriptional activity. NLS-mutant ARID1B from tumor samples shows cytoplasmic localization and activates ERK signaling.\",\n      \"method\": \"In silico NLS prediction, fluorescence subcellular localization, cellular fractionation, co-immunoprecipitation (cytoplasmic ARID1B with c-RAF/PPP1CA), xenograft assays, immunohistochemistry on tissue microarray\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — subcellular localization with functional consequences, direct binding by co-IP, in vivo xenograft, single lab\",\n      \"pmids\": [\"33443092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ARID1B knockdown in lung cancer cells increases DNA damage, impairs DNA repair, alters chromatin accessibility, and activates the cGAS-STING innate immune pathway.\",\n      \"method\": \"siRNA knockdown, γH2AX foci, ATAC-seq for chromatin accessibility, cGAS-STING pathway markers\",\n      \"journal\": \"Journal of Cancer\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, knockdown with pathway readout but limited mechanistic depth in abstract\",\n      \"pmids\": [\"38577613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ARID1B acts as a molecular suppressor of erythropoiesis under hypoxia. ARID1B knockdown in non-CMS (non-chronic mountain sickness) cells increases GATA1 expression by 3-fold and RBC levels by 100-fold under hypoxia. ARID1B modulates chromatin accessibility at GATA1/p53 target genes and controls p53 levels and EPO sensitivity.\",\n      \"method\": \"iPSC model system, siRNA knockdown, GATA1/p53 quantification, ATAC-seq for chromatin accessibility, RBC differentiation assays\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ATAC-seq chromatin evidence combined with functional erythropoiesis assay and GATA1/p53 quantification, single lab\",\n      \"pmids\": [\"35672450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The ARID domain of BAF250b (ARID1B) adopts a helix-turn-helix structure with a short β-sheet absent in its paralog BAF250a ARID. NMR chemical shift perturbations identified the DNA-binding interface of BAF250b ARID. Isothermal titration calorimetry showed moderate-affinity DNA binding with distinct thermodynamic signatures compared to BAF250a ARID.\",\n      \"method\": \"NMR backbone resonance assignment, backbone dynamics analysis, NMR chemical shift perturbations, HADDOCK structural modeling, isothermal titration calorimetry\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with functional DNA binding validation by ITC, single lab but two independent biophysical methods\",\n      \"pmids\": [\"35481652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Early postnatal fluoxetine (SSRI) treatment in Arid1b+/- mice prevents synaptic and behavioral deficits in adults by normalizing HDAC4/MEF2A-related transcriptional regulation of SynGAP1 and Arc, and upregulating FMRP target genes. Arid1b haploinsufficiency causes persistent decreases in excitatory synaptic density and transmission.\",\n      \"method\": \"Fluoxetine treatment during postnatal weeks 1-3, electrophysiology (mEPSC), transcriptomic analysis (RNA-seq), behavioral assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological rescue with transcriptomic mechanism identified, single lab\",\n      \"pmids\": [\"36030255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ARID1B blocks methionine-stimulated mTOR activation by binding to a specific region of the mTOR promoter and repressing mTOR transcription. Methionine reduces ARID1B binding to the mTOR promoter and decreases ARID1B protein levels via proteasomal degradation (MG132 but not chloroquine restores ARID1B). PI3K signaling mediates Met-induced reduction of ARID1B levels.\",\n      \"method\": \"ChIP for ARID1B at mTOR promoter, ARID1B knockdown/overactivation, mTOR reporter and protein phosphorylation assays, proteasome inhibitor experiments (MG132), cycloheximide chase\",\n      \"journal\": \"The Journal of nutritional biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP identifies direct promoter binding, proteasomal degradation mechanism established with multiple inhibitors, single lab\",\n      \"pmids\": [\"36681308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Protein destabilization is the main mechanism by which pathogenic missense mutations in ARID1B cause Coffin-Siris syndrome, as demonstrated by saturated mutagenesis screens.\",\n      \"method\": \"Saturated mutagenesis screens (deep mutational scanning)\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — saturated/deep mutagenesis screen systematically establishing mechanism across all missense positions\",\n      \"pmids\": [\"38347147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Pathogenic non-truncating ARID1B variants in the EHD2 and ARID domains cause protein misfolding and formation of cytoplasmic aggresomes surrounded by vimentin cage-like structures co-localizing with the MTOC. ARID domain variants also form nuclear aggregates. Protein levels are not reduced (NMD does not occur). The aggregation is attributed to exposure of amyloidogenic segments predicted by in silico structural analysis.\",\n      \"method\": \"Overexpression assays in cell lines, fluorescence microscopy (aggresome detection), quantitative western blot, in silico structural analysis, genome-wide transcriptome and methylation analysis\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct cellular imaging of protein aggregates, quantitative protein levels, structural prediction, single lab\",\n      \"pmids\": [\"39028335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ARID1B loss in the GLI1+ mesenchymal stem cell (MSC) lineage disrupts MSC quiescence and promotes their proliferation via ectopic activation of non-canonical Activin signaling through p-ERK. ARID1B suppresses Bcl11b expression by binding directly to the third intron of Bcl11b. BCL11B, a BAF complex subunit, promotes non-canonical Activin signaling by regulating Inhba (activin A subunit) expression. Reducing Bcl11b or non-canonical Activin signaling rescues the MSC phenotype.\",\n      \"method\": \"scRNA-seq, scATAC-seq, mouse incisor Arid1b conditional KO model, ChIP for ARID1B at Bcl11b locus, genetic rescue (Bcl11b reduction), ERK phosphorylation analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — scRNA-seq plus scATAC-seq plus direct ChIP binding at Bcl11b intron plus genetic rescue, multiple orthogonal methods in vivo\",\n      \"pmids\": [\"38816354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ARID1B controls chromatin accessibility at genomic regions targeted by TCF-like, NFI-like, and ARID-like transcription factors in callosal projection neurons expressing SATB2. In ARID1B+/- neural organoids, impaired SATB2+ neuron maturation and transcriptional dysregulation of corpus callosum development genes leads to defective long-range axonal projection formation.\",\n      \"method\": \"ARID1B+/- neural organoids, ATAC-seq for chromatin accessibility, RNA-seq, in vitro corpus callosum tract model for axonogenesis\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — ATAC-seq plus RNA-seq in human organoid model plus functional axonogenesis assay, multiple orthogonal methods\",\n      \"pmids\": [\"38718796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"mRNA display identified peptidic ligands that bind ARID1B with nanomolar affinity and high selectivity over ARID1A. Two distinct binding pockets were identified on ARID1B, one of which involves an ARID1B-exclusive cysteine residue that could allow covalent targeting.\",\n      \"method\": \"mRNA display (in vitro selection), biochemical binding assays, biophysical methods, chemical biology tools, competitive binding assays\",\n      \"journal\": \"ACS chemical biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding demonstrated with orthogonal methods, binding pockets mapped, single lab\",\n      \"pmids\": [\"38655884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ARID1B nuclear import is mediated by the KPNA2-KPNB1-RANBP2 cascade. Mutations at ARID1B residues R1518, H1519, and D1522 (to T1518, G1519, G1522) attenuate ARID1B-KPNA2/KPNB1 interaction and prevent ARID1B recruitment to the nuclear pore complex. Pharmacological inhibition of KPNB1 suppresses ARID1B translocation to the nucleus. ARID1B negatively regulates ARID1A in the nucleus.\",\n      \"method\": \"Protein complex purification, mass spectrometry, site-directed mutagenesis, co-immunoprecipitation, KPNB1 inhibitor treatment, ARID1B KO mouse tumor models\",\n      \"journal\": \"Advanced science (Weinheim, Baden-Wurttemberg, Germany)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mass spectrometry-identified complex, validated by co-IP and mutagenesis, single lab\",\n      \"pmids\": [\"40671262\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ARID1B is the DNA-binding scaffolding subunit of the cBAF-type SWI/SNF chromatin remodeling complex, mutually exclusive with its paralog ARID1A, where it binds BRG1/SMARCA4 via its EHD2 domain, binds DNA via its ARID domain (NMR-defined interface), and is imported into the nucleus via the KPNA2-KPNB1-RANBP2 cascade; it represses Wnt/β-catenin signaling through BRG1 and β-catenin association, suppresses mTOR transcription by direct promoter binding, maintains mesenchymal stem cell quiescence by repressing Bcl11b-driven non-canonical Activin/ERK signaling, is required for NHEJ-based DNA repair, regulates cortical GABAergic interneuron development through H3K9 acetylation of the Pvalb promoter, and controls chromatin accessibility at enhancers governing pluripotency exit and axonal projection programs; its loss of function causes complex disassembly (ARID1B scaffolding loss disrupts not only cBAF but also pBAF), pathogenic missense mutations primarily act through protein destabilization or aggregation, and cytoplasmic mislocalization confers oncogenic gain-of-function via RAF-ERK activation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ARID1B is the DNA-binding scaffolding subunit of cBAF-type SWI/SNF chromatin remodeling complexes, where it is mutually exclusive with its paralog ARID1A and controls chromatin accessibility programs governing proliferation, lineage transitions, and neuronal development [#0, #2, #15]. It binds the ATPase BRG1/SMARCA4 through its EHD2 domain and engages DNA through its ARID domain, which adopts a helix-turn-helix fold with a paralog-distinct β-sheet and binds DNA with moderate affinity [#0, #22]. Within the cell cycle, ARID1B is expressed throughout all phases and is required for ES cell self-renewal, G1-to-S progression, and timely cell cycle re-entry, such that its loss delays proliferation [#1, #2, #5]. ARID1B-BAF represses Wnt/β-catenin signaling by associating with β-catenin via its BRG1-binding domain, and this repression is central to its control of neurite outgrowth, chondro-/osteogenic bone growth, and neural progenitor behavior [#6, #14, #16]. During differentiation, cells switch from ARID1A-BAF to ARID1B-BAF, attenuating NANOG/SOX2 enhancers to drive exit from pluripotency, and ARID1B shapes accessibility at enhancers controlling cortical interneuron, callosal projection neuron, and dendritic maturation programs—including H3K9 acetylation of the Pvalb promoter and c-Fos/Arc-dependent dendritic arborization [#9, #10, #15, #28]. ARID1B also represses mTOR transcription by direct promoter binding and maintains GLI1+ mesenchymal stem cell quiescence by directly repressing Bcl11b to suppress non-canonical Activin/p-ERK signaling [#24, #27]. ARID1B and ARID1A are interdependent for complex stability and NHEJ repair, and combined loss disrupts both cBAF and pBAF, making ARID1B a selective vulnerability in ARID1A-mutant cancers [#3, #4, #12]. ARID1B nuclear import is driven by the KPNA2-KPNB1-RANBP2 and TNPO1 import machineries; NLS disruption mislocalizes ARID1B to the cytoplasm, where it binds c-RAF and PPP1CA to drive oncogenic RAF-ERK signaling [#17, #19, #30]. Pathogenic missense variants causing Coffin-Siris syndrome act predominantly through protein destabilization and, for EHD2/ARID-domain variants, misfolding into cytoplasmic aggresomes [#25, #26].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established ARID1B's basic architecture as a SWI/SNF subunit, defining how it physically anchors to the remodeling complex and proposing its DNA-contacting module.\",\n      \"evidence\": \"Domain mapping and co-IP from brain extracts localizing BRG1 binding to the EHD2 domain and identifying the ARID domain\",\n      \"pmids\": [\"11988099\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"DNA-binding activity of the ARID domain not demonstrated biochemically here\", \"no structural detail of EHD2-BRG1 interface\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrated that ARID1B-containing SWI/SNF is functionally required for stem cell self-renewal and cell cycle progression, moving beyond a structural role to cellular function.\",\n      \"evidence\": \"Biallelic inactivation in mouse ES cells with proliferation, self-renewal, and gene expression readouts\",\n      \"pmids\": [\"18323406\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"direct chromatin targets driving the phenotype not identified\", \"mechanism distinguishing ARID1B from ARID1A activity not addressed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Resolved how ARID1A and ARID1B are deployed differentially across the cell cycle, providing a basis for context-specific BAF assembly during proliferation versus arrest.\",\n      \"evidence\": \"Immunofluorescence and western blotting across synchronized cell cycle phases\",\n      \"pmids\": [\"21647563\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"functional consequence of differential incorporation not tested\", \"mechanism controlling mitotic ARID1A elimination unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified ARID1B as a synthetic-lethal vulnerability in ARID1A-mutant cancers and showed the paralogs are interdependent for complex stability and DNA double-strand break repair.\",\n      \"evidence\": \"shRNA/siRNA loss-of-function screens, complex stability assays, KU70/KU80 focus and clonogenic survival assays\",\n      \"pmids\": [\"24562383\", \"24788099\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"how residual complexes retain or lose specific functions not resolved\", \"direct chromatin remodeling step at DSBs not biochemically reconstituted\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Connected ARID1B dosage to disease-relevant cellular physiology by showing haploinsufficiency delays cell cycle re-entry in patient cells.\",\n      \"evidence\": \"BrdU/flow cytometry cell cycle analysis in patient-derived and knockdown fibroblasts\",\n      \"pmids\": [\"24674232\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"molecular targets linking ARID1B loss to delayed re-entry not defined\", \"single assay type\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined a key signaling output of ARID1B-BAF: repression of Wnt/β-catenin through BRG1- and β-catenin-dependent mechanisms, with relevance to neurite outgrowth.\",\n      \"evidence\": \"Wnt reporter assays, endogenous/exogenous co-IP, BRG1-binding-domain deletion mutants, neurite outgrowth assays; cell cycle knockdown in breast cancer cells\",\n      \"pmids\": [\"26340334\", \"25817822\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"genomic Wnt target loci not mapped\", \"whether repression occurs at chromatin or via β-catenin sequestration not distinguished\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Placed ARID1B within a defined oncogenic pathway and a neuronal differentiation program, showing it acts downstream of STAT3/β-catenin and is required for proper dendritic and synaptic development.\",\n      \"evidence\": \"Insertional mutagenesis screen with conditional mouse models and ChIP (neurofibroma); in utero electroporation knockdown with morphology, electrophysiology, and c-Fos/Arc rescue (neurons)\",\n      \"pmids\": [\"26904939\", \"26937011\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"direct ARID1B chromatin targets in neurons not fully enumerated\", \"how STAT3-driven repression of Arid1b is sustained not detailed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Provided in vivo mechanistic links between ARID1B haploinsufficiency and neurodevelopmental and growth phenotypes, including a specific histone-mark and promoter target.\",\n      \"evidence\": \"Arid1b heterozygous mice with cell counting, BrdU, H3K9ac ChIP at the Pvalb promoter, electrophysiology, and IGF1/GH measurement with GH rescue\",\n      \"pmids\": [\"29184203\", \"28695822\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether GABAergic and growth phenotypes share a common molecular target unknown\", \"how ARID1B loss reduces global H3K9ac mechanistically not resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed that ARID1B scaffolding loss disrupts both cBAF and pBAF and that paralog co-loss drives aggressive de-differentiated cancers, refining the synthetic-lethal model.\",\n      \"evidence\": \"Double-knockout mouse models, biochemical fractionation of SWI/SNF subcomplexes, scaffolding-domain mutations, senescence add-back assays; cell-type-specific interneuron conditional KOs with behavior\",\n      \"pmids\": [\"34386776\", \"32398858\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"mechanism by which residual cBAF subcomplexes poison pBAF not fully defined\", \"which BAF target genes mediate senescence not pinpointed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established ARID1B-BAF as a lineage-defining configuration that drives pluripotency exit and demonstrated its requirement for region-specific neurodevelopmental programs via β-catenin and chromatin accessibility.\",\n      \"evidence\": \"Patient iPSC multi-omics (ATAC-seq, ChIP-seq, RNA-seq, CUT&RUN) during cranial neural crest formation; conditional KO mouse models with β-catenin IF and behavior\",\n      \"pmids\": [\"34753942\", \"33594090\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"trigger initiating the ARID1A-to-ARID1B-BAF switch unknown\", \"direct enhancer targets shared across lineages not unified\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Expanded the regulatory and localization repertoire of ARID1B—nuclear import partners, paraspeckle/lncRNA association, erythropoietic suppression, and a cytoplasmic oncogenic gain-of-function.\",\n      \"evidence\": \"TNPO1 knockdown/co-IP with histone-mark ChIP and PI3K/AKT readouts; NEAT1 RIP and splicing RNA-seq; iPSC erythropoiesis with GATA1/p53 and ATAC-seq; NLS-mutant localization with c-RAF/PPP1CA co-IP and xenografts; cGAS-STING activation on knockdown\",\n      \"pmids\": [\"34044070\", \"36354291\", \"35672450\", \"33443092\", \"38577613\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"how cytoplasmic ARID1B engages RAF-ERK independent of BAF not structurally defined\", \"relationship between TNPO1 and KPNA2/KPNB1 import routes not reconciled\", \"cGAS-STING link is low-confidence and lacks mechanistic depth\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Provided the structural and biophysical basis for ARID1B DNA recognition and established paralog-distinguishing features of its ARID domain.\",\n      \"evidence\": \"NMR backbone assignment, chemical shift perturbation mapping, HADDOCK modeling, and ITC DNA-binding measurements; postnatal fluoxetine rescue of synaptic deficits with transcriptomic mechanism\",\n      \"pmids\": [\"35481652\", \"36030255\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"sequence specificity of ARID-domain DNA binding not defined\", \"structure of full ARID1B or its EHD2-BRG1 interface unsolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined transcriptional and metabolic control roles—direct mTOR promoter repression with nutrient-regulated degradation—and mapped the import cascade and ARID1B-ARID1A regulatory antagonism.\",\n      \"evidence\": \"ChIP at the mTOR promoter, proteasome-inhibitor and cycloheximide-chase experiments; mass-spectrometry complex purification with KPNA2/KPNB1/RANBP2 co-IP, mutagenesis, and KPNB1 inhibition\",\n      \"pmids\": [\"36681308\", \"40671262\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"whether mTOR promoter repression requires BAF remodeling not shown\", \"physiological signals routing ARID1B to nuclear pores versus cytoplasm not integrated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Resolved how ARID1B controls adult stem cell quiescence and neuronal connectivity at the level of direct target genes and accessibility, while establishing that Coffin-Siris missense variants act through destabilization or aggregation.\",\n      \"evidence\": \"scRNA/scATAC-seq with ARID1B ChIP at the Bcl11b intron and genetic rescue (MSC); ARID1B+/- organoid ATAC-seq/RNA-seq with axonogenesis assays; deep mutational scanning; aggresome imaging with structural prediction; mRNA-display ligand discovery\",\n      \"pmids\": [\"38816354\", \"38718796\", \"38347147\", \"39028335\", \"38655884\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether destabilizing and aggregating variants share downstream consequences not unified\", \"selective peptidic ligands not yet shown to modulate ARID1B function in cells\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single ARID1B-BAF complex is directed to such diverse, context-specific gene programs—and how cytoplasmic gain-of-function, nuclear import routing, and variant-induced destabilization are mechanistically connected—remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"no full-length structure of ARID1B within assembled BAF\", \"rules governing ARID1A-versus-ARID1B-BAF lineage switching unknown\", \"no unified model linking cytoplasmic, import, and aggregation phenotypes\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 22]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [6, 24, 27]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [18]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [3, 4, 12]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 19, 30]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [19, 26]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [10, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [10, 15, 21, 27, 28]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [6, 24, 27]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [1, 2, 5, 7]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 19, 27]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [9, 10, 15, 28]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [17, 30]}\n    ],\n    \"complexes\": [\"cBAF (SWI/SNF)\", \"pBAF (SWI/SNF)\"],\n    \"partners\": [\"SMARCA4\", \"ARID1A\", \"CTNNB1\", \"KPNA2\", \"KPNB1\", \"RANBP2\", \"TNPO1\", \"RAF1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}